diagnostic reagents | GenomeWeb

diagnostic reagents

Kits with the affected products may not be able to fully extract nucleic acids from samples and detect infection or provide a correct diagnosis.

The dispute stems from a licensing agreement in 2005 covering reagent patents held by Abaxis. Cepheid filed a countersuit yesterday, claiming it has not breached the license and asking the court to declare Abaxis' patents invalid.

Finnzymes had $20 million in revenues in 2009 and makes reagents, consumables, kits, and instruments for molecular biology applications.

The company will make and sell a Manchester-developed diagnostic reagent technology through an agreement that includes a research collaboration.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.